UCSF

Tagged: School of Pharmacy

CP159: Certificate in Resiliency Medicine Training: Immunizing for Stress

Sat Mar 9, 2019 - 8:30 am to 5:00 pm

About the course

We will explore the current research and demonstrate and practice resiliency building tools including a cross-section of mind-body interactions and internal narratives (story telling). Course completion requires teaching and modeling resiliency skills. Those who successfully complete the training will be awarded a certificate in resiliency training.

Gift of $500,000 honors Jere E. Goyan, late UCSF School of Pharmacy dean

The endowment will provide funds for a recipient to focus on delivering breakthroughs in therapeutics-related research, education, and patient care.

Creating an inexhaustible database for drug molecules

School of Pharmacy researchers helped a free public database of potential drug molecules grow 100-fold.

QBI fellowship fosters curiosity and perseverance for women scientists

Jacqueline Kyosiimire-Lugemwa, the first recipient of QBI’s Scholarship for Women from Developing Nations in Biosciences, spent a year at UCSF in which her perseverance in the sciences was tested. She recently returned to her home country of Uganda more ready than ever to tackle big questions about HIV.

Federal shutdown cancels CERSI conference aimed at health care cooperation

Federal shutdown cancels conference aimed at health care cooperation
Fri Jan 4, 2019

CRISPR-based obesity treatment shows promise for other diseases

A recent study by Nadav Ahituv, PhD, showed that obesity caused by a gene mutation could be treated in animal models.

COSA Winter Auction

Wed Feb 20, 2019 - 4:30 pm to 8:00 pm

Fraser appointed to Bowes Biomedical Investigator Program

Fraser developed several new tools for creating maps of macromolecules, a critical first step for finding new drugs.

Keiser receives $2.5 million to apply machine learning towards new therapies for Alzheimer’s, Parkinson’s

Michael Keiser, PhD, received a Ben Barres Early Career Acceleration Award from the Chan Zuckerberg Initiative, which will fund his research into novel therapies for neurodegeneration.

Combination drug therapy overcomes drug-resistant lung cancer in the lab

Many types of lung cancer thwart even the most targeted of therapies due to drug resistance, but a group of UCSF scientists led by Sourav Bandyopadhyay, PhD, have now shown that adding a second drug into treatment regimens can overcome this resistance in lab-grown, lung cancer cell lines.

Pages